In our interim analysis, we evaluated AD biomarkers of APP metabolism (Aβ1-40 and Aβ1-42), tau tangle pathology (p-tau 181 and p-tau 217), and neurodegeneration (NfL, GFAP) at a single timepoint and showed a strong association with age. This evidence concerns the gene GFAP and Alzheimer disease.